# Council Directive of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices (90/385/EEC), Division 3.2

Extent: E+W+S+N.I.

For devices intended for clinical investigations, the documentation shall also contain:
a general description of the product and its intended use,
design drawings, manufacturing methods, in particular as regards sterilization, and diagrams of parts, sub-assemblies, circuits, etc.,
the descriptions and explanations necessary for the understanding of the said drawings and diagrams and of the operation of the product,
the results of the risk analysis and a list of the standards laid down in Article 5, applied in full or in part, and a description of the solutions adopted to satisfy the essential requirements of the Directive where the standards in Article 5 have not been applied,
if the device incorporates, as an integral part, a substance or human blood derivative referred to in Section 10 of Annex 1, the data on the tests conducted in this connection which are required to assess the safety, quality and usefulness of that substance, or human blood derivative, taking account of the intended purpose of the device,
the results of the design calculations, checks and technical tests carried out, etc.
The manufacturer shall take all necessary measures to see that the manufacturing process ensures that the products manufactured conform to the documentation referred to in 3.1 and in the first paragraph of this section.
The manufacturer may authorize the evaluation, by audit where necessary, of the effectiveness of these measures.

---
Source: https://www.legislation.gov.uk/eudr/1990/385/annex/6/division/3/division/3.2 (the official version)
Page: https://openlegislation.uk/eu-directive-1990-385/annex-6/division-3/division-3.2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.